Thousands of people throughout the UK are experiencing a puzzling and severe dermatological condition that has stumped doctors. Sufferers experience their skin intensely inflamed with cracking and peeling, often across their entire bodies, yet many doctors have trouble diagnosing or treating the condition. The condition, called topical steroid withdrawal (TSW) or red skin syndrome, has generated significant attention on online platforms, with clips featuring patients’ experiences accumulating over one billion views on TikTok alone. Despite affecting a growing number of people, TSW is so little understood that some GPs and skin specialists doubt whether it exists at all. Now, for the very first time, researchers throughout Britain are launching a large-scale study to determine what is causing these unexplainable symptoms and reasons why some people develop the condition whereas others do not.
The Unexplained Ailment Spreading Across the UK
Bethany Gamble’s experience exemplifies the devastating impact of topical steroid withdrawal on sufferers’ lives. The 21-year-old from Birmingham had controlled her eczema successfully with steroid creams since childhood, but at eighteen, her condition took a dramatic turn for the worse. Her skin became intensely inflamed and red, breaking and leaking whilst the itching became what she refers to as “bone deep”. Within two years, the pain had become so acute that she was unable to leave her bed, requiring round-the-clock care from her mother. Most troubling, Bethany was repeatedly dismissed by doctors who attributed her symptoms to standard eczema and persistently prescribed the very treatments she suspected were triggering her suffering.
The medical establishment continues to disagree on how to manage TSW, with fundamental disagreement about its core nature. Some experts view it as a serious allergic reaction to the topical steroids that form the first-line treatment for eczema across the NHS. Others maintain it amounts to a serious exacerbation of existing skin conditions rather than a unique syndrome, whilst a minority are sceptical of its existence altogether. This lack of professional consensus has put patients like Bethany caught in a diagnostic uncertainty, having difficulty accessing appropriate treatment. The absence of agreement has led Professor Sara Brown at the University of Edinburgh to create the first major UK research project investigating TSW, funded by the National Eczema Society.
- Symptoms comprise severe inflammation, cracking skin and persistent pruritus across the body
- Patients describe “elephant skin” thickening and excessive flaking of keratinised cells
- Healthcare practitioners commonly disregard TSW as standard eczema or refuse to acknowledge it
- The condition may become so incapacitating that sufferers lack the capacity to perform daily activities
Living with Topical Steroid Withdrawal
From Mild Eczema to Severe Symptoms
For numerous sufferers, topical steroid withdrawal represents a severe decline from a formerly stable dermatological condition. What begins as intermittent itching in areas of skin fold can quickly progress into a widespread inflammatory reaction that leaves patients unable to function. The change typically happens abruptly, without warning, transforming a controllable long-term condition into an acute medical crisis. People describe their skin turning intensely hot, inflamed and red, with severe cracking and oozing that requires ongoing care. The bodily burden is compounded by fatigue, as the persistent itching prevents sleep and healing, establishing a vicious cycle of deterioration.
The speed at which TSW develops catches many sufferers off guard. Those who have experienced eczema for years, sometimes decades, are unprepared for the intensity of symptoms that emerge when their condition sharply declines. Routine activities become overwhelming difficulties: showering becomes agonising, dressing requires assistance, and keeping clean demands enormous effort. Some patients recount feeling as though their skin is being attacked from within, with inflammation moving through their body in patterns that show little similarity to their previous eczema flare-ups. This striking change often drives sufferers to pursue immediate medical attention, only to meet with doubt from healthcare professionals.
The Battle for Recognition
Perhaps the cruelest aspect of topical steroid withdrawal is the medical gaslighting that frequently accompanies it. Patients presenting with serious, unexplained health issues are routinely told they simply have eczema worsening, despite their insistence that this is fundamentally different from anything they’ve encountered previously. Doctors often respond by recommending higher-strength steroids or increased doses, possibly exacerbating the very condition patients suspect the topical treatments triggered. This cycle of dismissal leaves sufferers feeling abandoned by the medical establishment, forced to navigate their illness alone whilst being told their lived experience is invalid. Many patients report experiencing repeated invalidation, their concerns dismissed as emotional or psychological in nature rather than genuine physiological symptoms.
The absence of medical consensus has established a dangerous gap between patient experience and clinical acknowledgement. Without clear diagnostic criteria or defined treatment approaches, general practitioners and skin specialists struggle to identify TSW or offer appropriate support. Some clinicians remain entirely unconvinced the disorder is real, treating all severe presentations as typical eczema or recognised skin disorders. This professional uncertainty translates into diagnostic delays, unsuitable therapies and profound psychological distress for people experiencing physical symptoms. The increased prominence of TSW on social media has drawn attention to this diagnostic void, encouraging investigation to investigate what thousands of people claim to be experiencing, even as the medical establishment remains divided on how to respond.
- Symptoms can emerge suddenly in individuals with formerly controlled eczema treated by steroid creams
- Patients frequently encounter disbelief from medical practitioners who ascribe deterioration to standard eczema flares
- Healthcare providers remain divided on whether TSW is a real disorder or acute eczema flare-up
- Lack of established diagnostic standards means numerous patients find it difficult to obtain appropriate treatment and support
- Social media has amplified patient voices, with TSW hashtags accumulating over a billion views worldwide
Racial Disparities in Diagnosis and Care
The diagnostic complexities surrounding TSW become more acute amongst people with darker skin tones, where symptoms can be considerably more difficult to recognise visually. Erythema and inflammatory responses, the characteristic indicators of TSW in people with lighter skin, present distinctly across different ethnic groups, yet many diagnostic frameworks remain focused on how the condition appears in white patients. This gap means that individuals from Black, Asian and minority ethnic backgrounds experiencing TSW often face even greater delays in recognition and validation. Clinical practitioners trained chiefly via presentations in lighter skin may fail to recognise the typical indicators, leading to additional diagnostic errors and incorrect management approaches that can worsen symptoms.
Research into TSW has traditionally overlooked the experiences of people with darker complexions, sustaining a pattern where their symptoms remain under-documented and under-studied. The social media conversations dominating TSW discussions have been predominantly influenced by voices with lighter skin, risking distortion of medical understanding and public awareness. As Professor Sara Brown’s groundbreaking UK study advances, ensuring diverse representation amongst research participants will be essential to creating genuinely comprehensive diagnostic frameworks and therapeutic strategies. Without deliberate efforts to prioritise the perspectives of all ethnic groups, healthcare disparities in TSW identification and care risk widening further, abandoning at-risk communities without sufficient assistance or solutions.
| Skin Tone | TSW Appearance |
|---|---|
| Light/Fair | Bright red inflammation, visible flushing and erythema across affected areas |
| Medium/Olive | Darker red or brownish discolouration with less pronounced visible redness |
| Dark/Deep | Purple-toned or ashen discolouration, with inflammation appearing as hyperpigmentation or hypopigmentation |
| Very Dark | Subtle changes in skin texture and tone, with inflammation manifesting as dark patches or loss of pigmentation |
Emerging Research and Care Approaches Emerging
Initial Major UK Study In Progress
Professor Sara Brown’s groundbreaking research at the University of Edinburgh marks a significant milestone for TSW sufferers pursuing validation and understanding. Supported by the National Eczema Society, the study has recruited numerous participants across the UK to examine the physiological processes underlying topical steroid withdrawal. By assessing symptoms, saliva samples and skin biopsies, researchers hope to identify why particular individuals develop TSW whilst others on identical steroid regimens do not. This detailed analysis marks a important transition from dismissal to thorough inquiry.
The study team collaborating with Dr Alice Burleigh from patients’ support organisation Scratch That, brings both clinical expertise and personal experience to the research. Their collaborative approach recognises that patients hold essential understanding into their conditions. Professor Brown has identified patterns in TSW that cannot be accounted for by traditional understanding of eczema, including distinctive “elephant skin” thickening, extreme shedding and distinctly marked zones of inflammation. The study results could substantially alter how medical professionals manage diagnosis and treatment of this debilitating condition.
Available Treatments and Their Limitations
Presently, therapeutic approaches to TSW continue to be limited and often unsatisfactory. Many medical practitioners keep prescribing topical steroids despite evidence indicating they could worsen symptoms in susceptible individuals. Some patients note transient relief from emollients, antihistamines and systemic medications, though outcomes differ significantly. Dermatologists are split on most effective management plans, with some supporting total steroid discontinuation whilst others suggest slow reduction. This lack of consensus sees patients managing their treatment journeys mostly in isolation, drawing substantially on peer support networks and digital communities for guidance.
Psychological assistance with specialist dermatological care offer potential benefits, yet access is inconsistent across the NHS. Some patients have investigated complementary methods including changes to diet, environmental controls and holistic therapies, though scientific evidence validating such approaches is limited. The lack of established clinical protocols means treatment decisions frequently rely upon individual dermatologist experience and patient preference rather than research-informed standards. Until robust research yields conclusive findings, TSW sufferers frequently describe feeling abandoned by conventional medicine.
- Emollient creams and hydrating products to support the skin’s protective barrier and minimise water loss
- Antihistamine medications to control pruritus and associated sleep disruption in flare episodes
- Oral corticosteroids or immunosuppressants for serious presentations with specialist oversight
- Psychological counselling to manage emotional distress and worry stemming from chronic skin conditions
Expressions of Hope and Commitment
Despite the uncertainty surrounding TSW and the often dismissive attitudes from healthcare professionals, patients are gaining resilience in community and shared experience. Online support networks have proven vital for those battling the disorder, offering validation and practical advice when traditional medicine has failed them. Many individuals affected recount the moment they discovered the TSW hashtag as pivotal—finally finding others with the same symptoms and realising they were not alone in their experience. This collective voice has been powerful enough to prompt the first serious research efforts, demonstrating that patient-led campaigns can drive medical progress even when established institutions stay unconvinced.
Bethany Gamble and people in similar situations are committed to increase visibility and campaign for appropriate acknowledgement of TSW within the healthcare sector. Their readiness to recount personal stories of their difficulties on social media has encouraged open dialogue around a illness that various medical professionals still decline to recognise. These patients are not waiting passively for solutions; they are taking part in research studies, recording their manifestations thoroughly, and insisting that their testimonies be given proper consideration. Their determination in the face of persistent distress and dismissive healthcare practices suggests possibility that responses might prove to be within attainment, and that those to come will receive the recognition and support they urgently require.
- Patient-led research initiatives are filling gaps left by conventional healthcare systems and accelerating understanding of TSW
- Online communities provide psychological assistance, practical coping strategies, and mutual recognition for affected individuals globally
- Advocacy efforts are incrementally changing medical perception, encouraging dermatologists to examine rather than dismiss patient concerns
